1,50,000 Families Enrolled: A Major Step Forward in Prevention

On February 13, 2025, Sankalp India Foundation achieved a significant milestone in thalassemia and sickle cell disease prevention, enrolling 1,50,000 families in antenatal screening.

On February 13, 2025, Sankalp India Foundation achieved a significant milestone in thalassemia and sickle cell disease prevention, enrolling 1,50,000 families in antenatal screening.

Collected 789 units of life saving blood from 17 camps, impacting countless lives through generous donations
Transfused 3590 units in January in 23 daycare centres across 6 states, providing essential care and treatment to 2000+ affected children.

For families battling thalassemia, every day is a fight for survival. The hope of a cure through a bone marrow transplant (BMT) often feels out of reach due to limited facilities and high costs. In a step toward changing this reality Sankalp India Foundation with the partnership of DKMS Foundation India and Cure2Children have expanded the BMT unit at Health1 Hospital, Ahmedabad.